The disclosure relates to the field of imaging, and particularly to the estimation of a pose of an imaging device and to three-dimensional imaging of body organs.
Pose estimation of an imaging device, such as a camera or a fluoroscopic device, may be required or used for variety of applications, including registration between different imaging modalities or the generation of augmented reality. One of the known uses of a pose estimation of an imaging device is the construction of a three-dimensional volume from a set of two-dimensional images captured by the imaging device while in different poses. Such three-dimensional construction is commonly used in the medical field and has a significant impact.
There are several commonly applied medical methods, such as endoscopic procedures or minimally invasive procedures, for treating various maladies affecting organs including the liver, brain, heart, lung, gall bladder, kidney and bones. Often, one or more imaging modalities, such as magnetic resonance imaging, ultrasound imaging, computed tomography (CT), fluoroscopy as well as others are employed by clinicians to identify and navigate to areas of interest within a patient and ultimately targets for treatment. In some procedures, pre-operative scans may be utilized for target identification and intraoperative guidance. However, real-time imaging may be often required in order to obtain a more accurate and current image of the target area. Furthermore, real-time image data displaying the current location of a medical device with respect to the target and its surrounding may be required in order to navigate the medical device to the target in a more safe and accurate manner (e.g., with unnecessary or no damage caused to other tissues and organs).
According to one aspect of the disclosure, a system for constructing fluoroscopic-based three-dimensional volumetric data of a target area within a patient from two-dimensional fluoroscopic images acquired via a fluoroscopic imaging device is provided. The system includes a structure of markers and a computing device. A sequence of images of the target area and of the structure of markers is acquired via the fluoroscopic imaging device. The computing device is configured to estimate a pose of the fluoroscopic imaging device for a plurality of images of the sequence of images based on detection of a possible and most probable projection of the structure of markers as a whole on each image of the plurality of images, and construct fluoroscopic-based three-dimensional volumetric data of the target area based on the estimated poses of the fluoroscopic imaging device.
In an aspect, the computing device is further configured to facilitate an approach of a medical device to the target area, wherein a medical device is positioned in the target area prior to acquiring the sequence of images, and determine an offset between the medical device and the target based on the fluoroscopic-based three-dimensional volumetric data.
In an aspect, the system further comprises a locating system indicating a location of the medical device within the patient. Additionally, the computing device may be further configured to display the target area and the location of the medical device with respect to the target, facilitate navigation of the medical device to the target area via the locating system and the display, and correct the display of the location of the medical device with respect to the target based on the determined offset between the medical device and the target.
In an aspect, the computing device is further configured to display a 3D rendering of the target area on the display, and register the locating system to the 3D rendering, wherein correcting the display of the location of the medical device with respect to the target comprises updating the registration between the locating system and the 3D rendering.
In an aspect, the locating system is an electromagnetic locating system.
In an aspect, the target area comprises at least a portion of lungs and the medical device is navigable to the target area through airways of a luminal network.
In an aspect, the structure of markers is at least one of a periodic pattern or a two-dimensional pattern. The target area may include at least a portion of lungs and the target may be a soft tissue target.
In yet another aspect of the disclosure, a method for constructing fluoroscopic-based three dimensional volumetric data of a target area within a patient from a sequence of two-dimensional (2D) fluoroscopic images of a target area and of a structure of markers acquired via a fluoroscopic imaging device is provided. The structure of markers is positioned between the patient and the fluoroscopic imaging device. The method includes using at least one hardware processor for estimating a pose of the fluoroscopic imaging device for at least a plurality of images of the sequence of 2D fluoroscopic images based on detection of a possible and most probable projection of the structure of markers as a whole on each image of the plurality of images, and constructing fluoroscopic-based three-dimensional volumetric data of the target area based on the estimated poses of the fluoroscopic imaging device.
In an aspect, a medical device is positioned in the target area prior to acquiring the sequence of images, and wherein the method further comprises using the at least one hardware processor for determining an offset between the medical device and the target based on the fluoroscopic-based three-dimensional volumetric data.
In an aspect, the method further includes facilitating navigation of the medical device to the target area via a locating system indicating a location of the medical device and via a display, and correcting a display of the location of the medical device with respect to the target based on the determined offset between the medical device and the target.
In an aspect, the method further includes displaying a 3D rendering of the target area on the display, and registering the locating system to the 3D rendering, where the correcting of the location of the medical device with respect to the target comprises updating the registration of the locating system to the 3D rendering.
In an aspect, the method further includes using the at least one hardware processor for generating the 3D rendering of the target area based on previously acquired CT volumetric data of the target area.
In an aspect, the target area includes at least a portion of lungs and the medical device is navigable to the target area through airways of a luminal network.
In an aspect, the structure of markers is at least one of a periodic pattern or a two-dimensional pattern. The target area may include at least a portion of lungs and the target may be a soft-tissue target.
In yet another aspect of the disclosure, a system for constructing fluoroscopic-based three-dimensional volumetric data of a target area within a patient from two-dimensional fluoroscopic images acquired via a fluoroscopic imaging device is provided. The system includes a computing device configured to estimate a pose of the fluoroscopic imaging device for a plurality of images of a sequence of images based on detection of a possible and most probable projection of a structure of markers as a whole on each image of the plurality of images, and construct fluoroscopic-based three-dimensional volumetric data of the target area based on the estimated poses of the fluoroscopic imaging device.
In an aspect, the computing device is further configured to facilitate an approach of a medical device to the target area, wherein a medical device is positioned in the target area prior to acquisition of the sequence of images, and determine an offset between the medical device and the target based on the fluoroscopic-based three-dimensional volumetric data.
In an aspect, the computing device is further configured to display the target area and the location of the medical device with respect to the target, facilitate navigation of the medical device to the target area via the locating system and the display, and correct the display of the location of the medical device with respect to the target based on the determined offset between the medical device and the target.
In an aspect, the computing device is further configured to display a 3D rendering of the target area on the display, and register the locating system to the 3D rendering, wherein correcting the display of the location of the medical device with respect to the target comprises updating the registration between the locating system and the 3D rendering.
Various exemplary embodiments are illustrated in the accompanying figures with the intent that these examples not be restrictive. It will be appreciated that for simplicity and clarity of the illustration, elements shown in the figures referenced below are not necessarily drawn to scale. Also, where considered appropriate, reference numerals may be repeated among the figures to indicate like, corresponding or analogous elements. The figures are listed below.
Prior art methods and systems for pose estimation may be inappropriate for real time use, inaccurate or non-robust. Therefore, there is a need for a method and system, which provide a relatively fast, accurate and robust pose estimation, particularly in the field of medical imaging.
In order to navigate medical devices to a remote target for example, for biopsy or treatment, both the medical device and the target should be visible in some sort of a three-dimensional guidance system. When the target is a small soft-tissue object, such as a tumor or a lesion, an X-ray volumetric reconstruction is needed in order to be able to identify it. Several solutions exist that provide three-dimensional volume reconstruction such as CT and Cone-beam CT which are extensively used in the medical world. These machines algorithmically combine multiple X-ray projections from known, calibrated X-ray source positions into three dimensional volume in which, inter alia, soft-tissues are visible. For example, a CT machine can be used with iterative scans during procedure to provide guidance through the body until the tools reach the target. This is a tedious procedure as it requires several full CT scans, a dedicated CT room and blind navigation between scans. In addition, each scan requires the staff to leave the room due to high-levels of ionizing radiation and exposes the patient to such radiation. Another option is a Cone-beam CT machine which is available in some operation rooms and is somewhat easier to operate, but is expensive and like the CT only provides blind navigation between scans, requires multiple iterations for navigation and requires the staff to leave the room. In addition, a CT-based imaging system is extremely costly, and in many cases not available in the same location as the location where a procedure is carried out.
A fluoroscopic imaging device is commonly located in the operating room during navigation procedures. The standard fluoroscopic imaging device may be used by a clinician, for example, to visualize and confirm the placement of a medical device after it has been navigated to a desired location. However, although standard fluoroscopic images display highly dense objects such as metal tools and bones as well as large soft-tissue objects such as the heart, the fluoroscopic images have difficulty resolving small soft-tissue objects of interest such as lesions. Furthermore, the fluoroscope image is only a two-dimensional projection, while in order to accurately and safely navigate within the body, a volumetric or three-dimensional imaging is required.
An endoscopic approach has proven useful in navigating to areas of interest within a patient, and particularly so for areas within luminal networks of the body such as the lungs. To enable the endoscopic, and more particularly the bronchoscopic, approach in the lungs, endobronchial navigation systems have been developed that use previously acquired MRI data or CT image data to generate a three dimensional rendering or volume of the particular body part such as the lungs.
The resulting volume generated from the MRI scan or CT scan is then utilized to create a navigation plan to facilitate the advancement of a navigation catheter (or other suitable medical device) through a bronchoscope and a branch of the bronchus of a patient to an area of interest. A locating system, such as an electromagnetic tracking system, may be utilized in conjunction with the CT data to facilitate guidance of the navigation catheter through the branch of the bronchus to the area of interest. In certain instances, the navigation catheter may be positioned within one of the airways of the branched luminal networks adjacent to, or within, the area of interest to provide access for one or more medical instruments.
As another example, minimally invasive procedures, such as laparoscopy procedures, including robotic-assisted surgery, may employ intraoperative fluoroscopy in order to increase visualization, e.g., for guidance and lesion locating, or in order to prevents injury and complications.
Therefore, a fast, accurate and robust three-dimensional reconstruction of images is required, which is generated based on a standard fluoroscopic imaging performed during medical procedures.
Reference is now made to
The probability map may be generated, for example, by feeding the image into a simple marker (blob) detector, such as a Harris corner detector, which outputs a new image of smooth densities, corresponding to the probability of each pixel to belong to a marker.
In a step 110, different candidates may be generated for the projection of the structure of markers on the image. The different candidates may be generated by virtually positioning the imaging device in a range of different possible poses. By “possible poses” of the imaging device, it is meant three-dimensional positions and orientations of the imaging device. In some embodiments, such a range may be limited according to the geometrical structure and/or degrees of freedom of the imaging device. For each such possible pose, a virtual projection of at least a portion of the structure of markers is generated, as if the imaging device actually captured an image of the structure of markers while positioned at that pose.
In a step 120, the candidate having the highest probability of being the projection of the structure of markers on the image may be identified based on the image probability map. Each candidate, e.g., a virtual projection of the structure of markers, may be overlaid or associated to the probability map. A probability score may be then determined or associated with each marker projection of the candidate. In some embodiments, the probability score may be positive or negative, e.g., there may be a cost in case virtual markers projections falls within pixels of low probability. The probability scores of all of the markers projections of a candidate may be then summed and a total probability score may be determined for each candidate. For example, if the structure of markers is a two-dimensional grid, then the projection will have a grid form. Each point of the projection grid would lie on at least one pixel of the probability map. A 2D grid candidate will receive the highest probability score if its points lie on the highest density pixels, that is, if its points lie on projections of the centeres of the markers on the image. The candidate having the highest probability score may be determined as the candidate which has the highest probability of being the projection of the structure of markers on the image. The pose of the imaging device for the image may be then estimated based on the virtual pose of the imaging device used to generate the identified candidate.
Further steps may be performed in order to refine the above described pose estimation. In an optional step 130, a locally deformed version of the candidate may be generated in order to maximize its probability of being the projection of the structure of markers on the image. The locally deformed version may be generated based on the image probability map. A local search algorithm may be utilized to deform the candidate so that it would maximize its score. For example, in case the structure of markers is a 2D grid, each 2D grid point may be treated individually. Each point may be moved towards the neighbouring local maxima on the probability map using gradient ascent method.
In an optional step 140, an improved candidate for the projection of the structure of markers on the image may be detected based on the locally deformed version of the candidate. The improved candidate is determined such that it fits (exactly or approximately) the locally deformed version of the candidate. Such improved candidate may be determined by identifying a transformation that will fit a new candidate to the local deformed version, e.g., by using homography estimation methods. The virtual pose of the imaging device associated with the improved candidate may be then determined as the estimated pose of the imaging device for the image.
In some embodiments, the generation of a locally deformed version of the candidate and the determination of an improved candidate may be iteratively repeated. These steps may be iteratively repeated until the process converges to a specific virtual projection of the structure of markers on the image, which may be determined as the improved candidate. Thus, since the structure of markers converges as a whole, false local maxima is avoided. In an aspect, as an alternative to using a list of candidates and finding an optimal candidate for estimating the camera pose, the camera pose may be estimated by solving a homography that transforms a 2D fiducial structure in 3D space into image coordinates that matches the fiducial probability map generated from the imaging device output.
In some embodiments, the imaging device may be configured to capture a sequence of images. A sequence of images may be captured, automatically or manually, by continuously sweeping the imaging device at a certain angle. When pose estimation of a sequence of images is required, the estimation process may become more efficient by reducing the range or area of possible virtual poses for the imaging device. A plurality of non-sequential images of the sequence of images may be then determined. For example, the first image in the sequence, the last image, and one or more images in-between. The one or more images in-between may be determined such that the sequence is divided into equal image portions. At a first stage, the pose of the imaging device may be estimated only for the determined non-sequential images. At a second stage, the area or range of possible different poses for virtually positioning the imaging device may be reduced. The reduction may be performed based on the estimated poses of the imaging device for the determined non-sequential images. The pose of the imaging device for the rest of the images may be then estimated according to the reduced area or range. For example, the pose of the imaging device for the first and tenth images of the sequence are determined at the first stage. The pose of the imaging device for the second to ninth images must be along a feasible and continuous path between its pose for the first image and its pose for the tenth image, and so on.
In some embodiments, geometrical parameters of the imaging device may be pre-known, or pre-determined, such as the field of view of the source, height range, rotation angle range and the like, including the device degrees of freedom (e.g., independent motions allowed). In some embodiments, such geometrical parameters of the imaging device may be determined in real-time while estimating the pose of the imaging device for the captured images. Such information may be also used to reduce the area or range of possible poses. In some embodiments, a user practicing the disclosed disclosure may be instructed to limit the motion of the imaging device to certain degrees of freedom or to certain ranges of motion for the sequence of images. Such limitations may be also considered when determining the imaging device possible poses and thus may be used to make the imaging device pose estimation faster.
In some embodiments, an image pre-processing methods may be first applied to the one or more images in order to correct distortions and/or enhance the visualization of the projection of the structure of markers on the image. For example, in case the imaging device is a fluoroscope, correction of “pincushion” distortion, which slightly warps the image, may be performed. This distortion may be automatically addressed by modeling the warp with a polynomial surface and applying compatible warp which will cancel out the pincushion effect. In case a grid of metal spheres is used, the image may be inversed in order to enhance the projections of the markers. In addition, the image may be blurred using Gaussian filter with sigma value equal, for example, to one half of the spheres diameter, in order to facilitate the search and evaluation of candidates as disclosed above.
In some embodiments, one or more models of the imaging device may be calibrated to generate calibration data, such as a data file, which may be used to automatically calibrate the specific imaging device. The calibration data may include data referring to the geometric calibration and/or distortion calibration, as disclosed above. In some embodiments, the geometric calibration may be based on data provided by the imaging device manufacturer. In some embodiments, a manual distortion calibration may be performed once for a specific imaging device. In an aspect, the imaging device distortion correction can be calibrated as a preprocessing step during every procedure as the pincushion distortion may change as a result of imaging device maintenance or even as a result of a change in time.
Memory 202 may include any non-transitory computer-readable storage media for storing data and/or software including instructions that are executable by processor 204 and which control the operation of workstation 80 and in some embodiments, may also control the operation of imaging device 215. In an embodiment, memory 202 may include one or more solid-state storage devices such as flash memory chips. Alternatively, or in addition to the one or more solid-state storage devices, memory 202 may include one or more mass storage devices connected to the processor 204 through a mass storage controller (not shown) and a communications bus (not shown). Although the description of computer-readable media contained herein refers to a solid-state storage, it should be appreciated by those skilled in the art that computer-readable storage media can be any available media that can be accessed by the processor 204. That is, computer readable storage media may include non-transitory, volatile and non-volatile, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable instructions, data structures, program modules or other data. For example, computer-readable storage media may include RAM, ROM, EPROM, EEPROM, flash memory or other solid-state memory technology, CD-ROM, DVD, Blu-Ray or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which may be used to store the desired information and which may be accessed by workstation 80.
Application 81 may, when executed by processor 204, cause display 206 to present user interface 216. Network interface 208 may be configured to connect to a network such as a local area network (LAN) consisting of a wired network and/or a wireless network, a wide area network (WAN), a wireless mobile network, a Bluetooth network, and/or the internet. Network interface 208 may be used to connect between workstation 80 and imaging device 215. Network interface 208 may be also used to receive image data 214. Input device 210 may be any device by means of which a user may interact with workstation 80, such as, for example, a mouse, keyboard, foot pedal, touch screen, and/or voice interface. Output module 212 may include any connectivity port or bus, such as, for example, parallel ports, serial ports, universal serial busses (USB), or any other similar connectivity port known to those skilled in the art.
Imaging device 215 may be any imaging device, which captures 2D images, such as a standard fluoroscopic imaging device or a camera. In some embodiments, markers structure 218, may be a structure of markers having a two-dimensional pattern, such as a grid having two dimensions of width and length (e.g., 2D grid), as shown in
Referring now to
Referring now back to
In a step 710, a pose of the fluoroscopic imaging device for at least a plurality of images of the sequence of images may be estimated. The pose estimation may be performed based on detection of a possible and most probable projection of the structure of markers as a whole on each image of the plurality of images, and as described with respect to
In some embodiments, other methods for estimating the pose of the fluoroscopic device may be used. There are various known methods for determining the poses of imaging devices, such as an external angle measuring device or based on image analysis. Some of such devices and methods are particularly described in commonly-owned U.S. Patent Publication No. 2017/0035379, filed on Aug. 1, 2016, by Weingarten et al, the entire content of which is hereby incorporated by reference.
In a step 720, a fluoroscopic-based three-dimensional volumetric data of the target area may be constructed based on the estimated poses of the fluoroscopic imaging device. Exemplary systems and methods for constructing such fluoroscopic-based three-dimensional volumetric data are disclosed in the above commonly-owned U.S. Patent Publication No. 2017/0035379, which is incorporated by reference.
In an optional step 730, a medical device may be positioned in the target area prior to the acquiring of the sequence of images. Thus, the sequence of images and consequently the fluoroscopic-based three-dimensional volumetric data may also include a projection of the medical device in addition to the target. The offset (i.e., Δx, Δy and Δz) between the medical device and the target may be then determined based on the fluoroscopic-based three-dimensional volumetric data. The target may be visible or better exhibited in the generated three-dimensional volumetric data. Therefore, the target may be detected, automatically, or manually by the user, in the three-dimensional volumetric data. The medical device may be detected, automatically or manually by a user, in the sequence of images, as captured, or in the generated three-dimensional volumetric data. The automatic detection of the target and/or the medical device may be performed based on systems and methods as known in the art and such as described, for example, in commonly-owned U.S. Patent Application No. 62/627,911, titled: “SYSTEM AND METHOD FOR CATHETER DETECTION IN FLUOROSCOPIC IMAGES AND UPDATING DISPLAYED POSITION OF CATHETER”, filed on Feb. 8, 2018, by Birenbaum et al. The manual detection may be performed by displaying to the user the three-dimensional volumetric data and/or captured images and requesting his input. Once the target and the medical device are detected in the three-dimensional volumetric data and/or the captures images, their location in the fluoroscopic coordinate system of reference may be obtained and the offset between them may be determined.
The offset between the target and the medical device may be utilized for various medical purposes, including facilitating approach of the medical device to the target area and treatment. The navigation of a medical device to the target area may be facilitated via a locating system and a display. The locating system locates or tracks the motion of the medical device through the patient's body. The display may display the medical device location to the user with respect to the surroundings of the medical device within the patient's body and the target. The locating system may be, for example, an electromagnetic or optic locating system, or any other such system as known in the art. When, for example, the target area includes a portion of the lungs, the medical device may be navigated to the target area through the airways luminal network and as described with respect to
In an optional step 740, a display of the location of the medical device with respect to the target may be corrected based on the determined offset between the medical device and the target. In some embodiments, a 3D rendering of the target area may be displayed on the display. The 3D rendering of the target area may be generated based on CT volumetric data of the target area which was acquired previously, e.g., prior to the current procedure or operation (e.g., preoperative CT). In some embodiments, the locating system may be registered to the 3D rendering of the target, such as described, for example, with respect to
In some embodiments, the updating of the registration of the locating system to the 3D rendering (e.g., CT-base) may be performed in a local manner and/or in a gradual manner. For example, the registration may be updated only in the surroundings of the target, e.g., only within a certain distance from the target. This is since the update may be less accurate when not performed around the target. In some embodiments, the updating may be performed in a gradual manner, e.g., by applying weights according to distance from the target. In addition to accuracy considerations, such gradual updating may be more convenient or easier for the user to look at, process and make the necessary changes during procedure, than abrupt change in the medical device location on the display.
In some embodiments, the patient may be instructed to stop breathing (or caused to stop breathing) during the capture of the images in order to prevent movements of the target area due to breathing. In other embodiments, methods for compensating breathing movements during the capture of the images may be performed. For example, the estimated poses of the fluoroscopic device may be corrected according to the movements of a fiducial marker placed in the target area. Such a fiducial may be a medical device, e.g., a catheter, placed in the target area. The movement of the catheter, for example, may be determined based on the locating system. In some embodiments, a breathing pattern of the patient may be determined according to the movements of a fiducial marker, such as a catheter, located in the target area. The movements may be determined via a locating system. Based on that pattern, only images of inhale or exhale may be considered when determining the pose of the imaging device.
In embodiments, as described above, for each captured frame, the imaging device three-dimensional position and orientation are estimated based on a set of static markers positioned on the patient bed. This process requires knowledge about the markers 3D positions in the volume, as well as the compatible 2D coordinates of the projections in the image plane. Adding one or more markers from different planes in the volume of interest may lead to more robust and accurate pose estimation. One possible marker that can be utilized in such a process is the catheter tip (or other medical device tip positioned through the catheter). The tip is visible throughout the video captured by fluoroscopic imaging and the compatible 3D positions may be provided by a navigation or tracking system (e.g., an electromagnetic navigation tracking system) as the tool is navigated to the target (e.g., through the electromagnetic field). Therefore, the only remaining task is to deduce the exact 2D coordinates from the video frames. As described above, one embodiment of the tip detection step may include fully automated detection and tracking of the tip throughout the video. Another embodiment may implement semi-supervised tracking in which the user manually marks the tip in one or more frames and the detection process computes the tip coordinates for the rest of the frames.
In embodiments, the semi-supervised tracking process may be implemented in accordance with solving each frame at a time by template matching between current frame and previous ones, using optical flow to estimate the tip movement along the video, and/or model-based trackers. Model-based trackers train a detector to estimate the probability of each pixel to belong to the catheter tip, which is followed by a step of combining the detections to a single most probable list of coordinates along the video. One possible embodiment of the model-based trackers involves dynamic programming. Such an optimization approach enables finding a seam (connected list of coordinates along the video frames 3D space—first two dimensions belongs to the image plane and the third axis is time) with maximal probability. Another possible way to achieve a seam of two-dimensional coordinates is training a detector to estimate the tip coordinate in each frame while incorporating a regularization to the loss function of proximity between detections in adjacent frames.
System 800 may be configured for reviewing CT image data to identify one or more targets, planning a pathway to an identified target (planning phase), navigating an extended working channel (EWC) 812 of a catheter assembly to a target (navigation phase) via a user interface, and confirming placement of EWC 812 relative to the target. One such EMN system is the ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY® system currently sold by Medtronic PLC. The target may be tissue of interest identified by review of the CT image data during the planning phase. Following navigation, a medical device, such as a biopsy tool or other tool, may be inserted into EWC 812 to obtain a tissue sample from the tissue located at, or proximate to, the target.
System 800 generally includes an operating table 820 configured to support a patient “P,” a bronchoscope 830 configured for insertion through the patient's “P's” mouth into the patient's “P's” airways; monitoring equipment 835 coupled to bronchoscope 830 (e.g., a video display, for displaying the video images received from the video imaging system of bronchoscope 830); a locating system 850 including a locating module 852, a plurality of reference sensors 854 and a transmitter mat coupled to a structure of markers 856; and a computing device 825 including software and/or hardware used to facilitate identification of a target, pathway planning to the target, navigation of a medical device to the target, and confirmation of placement of EWC 812, or a suitable device therethrough, relative to the target. Computing device 825 may be similar to workstation 80 of
A fluoroscopic imaging device 810 capable of acquiring fluoroscopic or x-ray images or video of the patient “P” is also included in this particular aspect of system 800. The images, sequence of images, or video captured by fluoroscopic imaging device 810 may be stored within fluoroscopic imaging device 810 or transmitted to computing device 825 for storage, processing, and display, as described with respect to
Computing device 185 may be any suitable computing device including a processor and storage medium, wherein the processor is capable of executing instructions stored on the storage medium. Computing device 185 may further include a database configured to store patient data, CT data sets including CT images, fluoroscopic data sets including fluoroscopic images and video, navigation plans, and any other such data. Although not explicitly illustrated, computing device 185 may include inputs, or may otherwise be configured to receive, CT data sets, fluoroscopic images/video and other data described herein. Additionally, computing device 185 includes a display configured to display graphical user interfaces. Computing device 185 may be connected to one or more networks through which one or more databases may be accessed.
With respect to the planning phase, computing device 185 utilizes previously acquired CT image data for generating and viewing a three dimensional model of the patient's “P's” airways, enables the identification of a target on the three dimensional model (automatically, semi-automatically, or manually), and allows for determining a pathway through the patient's “P's” airways to tissue located at and around the target. More specifically, CT images acquired from previous CT scans are processed and assembled into a three-dimensional CT volume, which is then utilized to generate a three-dimensional model of the patient's “P's” airways. The three-dimensional model may be displayed on a display associated with computing device 185, or in any other suitable fashion. Using computing device 185, various views of the three-dimensional model or enhanced two-dimensional images generated from the three-dimensional model are presented. The enhanced two-dimensional images may possess some three-dimensional capabilities because they are generated from three-dimensional data. The three-dimensional model may be manipulated to facilitate identification of target on the three-dimensional model or two-dimensional images, and selection of a suitable pathway through the patient's “P's” airways to access tissue located at the target can be made. Once selected, the pathway plan, three dimensional model, and images derived therefrom, can be saved and exported to a navigation system for use during the navigation phase(s). One such planning software is the ILOGIC® planning suite currently sold by Medtronic PLC.
With respect to the navigation phase, a six degrees-of-freedom electromagnetic locating or tracking system 850, e.g., similar to those disclosed in U.S. Pat. Nos. 8,467,589, 6,188,355, and published PCT Application Nos. WO 00/10456 and WO 01/67035, the entire contents of each of which are incorporated herein by reference, or other suitable positioning measuring system, is utilized for performing registration of the images and the pathway for navigation, although other configurations are also contemplated. Tracking system 850 includes a locating or tracking module 852, a plurality of reference sensors 854, and a transmitter mat 856. Tracking system 850 is configured for use with a locatable guide 832 and particularly sensor 844. As described above, locatable guide 832 and sensor 844 are configured for insertion through an EWC 182 into a patient's “P's” airways (either with or without bronchoscope 830) and are selectively lockable relative to one another via a locking mechanism.
Transmitter mat 856 is positioned beneath patient “P.” Transmitter mat 856 generates an electromagnetic field around at least a portion of the patient “P” within which the position of a plurality of reference sensors 854 and the sensor 844 can be determined with use of a tracking module 852. One or more of reference sensors 854 are attached to the chest of the patient “P.” The six degrees of freedom coordinates of reference sensors 854 are sent to computing device 825 (which includes the appropriate software) where they are used to calculate a patient coordinate frame of reference. Registration, is generally performed to coordinate locations of the three-dimensional model and two-dimensional images from the planning phase with the patient's “P's” airways as observed through the bronchoscope 830, and allow for the navigation phase to be undertaken with precise knowledge of the location of the sensor 844, even in portions of the airway where the bronchoscope 830 cannot reach. Further details of such a registration technique and their implementation in luminal navigation can be found in U.S. Patent Application Pub. No. 2011/0085720, the entire content of which is incorporated herein by reference, although other suitable techniques are also contemplated.
Registration of the patient's “P's” location on the transmitter mat 856 is performed by moving LG 832 through the airways of the patient's “P.” More specifically, data pertaining to locations of sensor 844, while locatable guide 832 is moving through the airways, is recorded using transmitter mat 856, reference sensors 854, and tracking module 852. A shape resulting from this location data is compared to an interior geometry of passages of the three dimensional model generated in the planning phase, and a location correlation between the shape and the three dimensional model based on the comparison is determined, e.g., utilizing the software on computing device 825. In addition, the software identifies non-tissue space (e.g., air filled cavities) in the three-dimensional model. The software aligns, or registers, an image representing a location of sensor 844 with the three-dimensional model and two-dimensional images generated from the three-dimension model, which are based on the recorded location data and an assumption that locatable guide 832 remains located in non-tissue space in the patient's “P's” airways. Alternatively, a manual registration technique may be employed by navigating the bronchoscope 830 with the sensor 844 to pre-specified locations in the lungs of the patient “P”, and manually correlating the images from the bronchoscope to the model data of the three dimensional model.
Following registration of the patient “P” to the image data and pathway plan, a user interface is displayed in the navigation software which sets for the pathway that the clinician is to follow to reach the target. One such navigation software is the ILOGIC® navigation suite currently sold by Medtronic PLC.
Once EWC 812 has been successfully navigated proximate the target as depicted on the user interface, the locatable guide 832 may be unlocked from EWC 812 and removed, leaving EWC 812 in place as a guide channel for guiding medical devices including without limitation, optical systems, ultrasound probes, marker placement tools, biopsy tools, ablation tools (i.e., microwave ablation devices), laser probes, cryogenic probes, sensor probes, and aspirating needles to the target.
The disclosed exemplary system 800 may be employed by the method of
System 800 or similar version of it in conjunction with the method of
Systems and methods in accordance with the disclosure may be usable for facilitating the navigation of a medical device to a target and/or its area using real-time two-dimensional fluoroscopic images of the target area. The navigation is facilitated by using local three-dimensional volumetric data, in which small soft-tissue objects are visible, constructed from a sequence of fluoroscopic images captured by a standard fluoroscopic imaging device available in most procedure rooms. The fluoroscopic-based constructed local three-dimensional volumetric data may be used to correct a location of a medical device with respect to a target or may be locally registered with previously acquired volumetric data (e.g., CT data). In general, the location of the medical device may be determined by a tracking system, for example, an electromagnetic tracking system. The tracking system may be registered with the previously acquired volumetric data. A local registration of the real-time three-dimensional fluoroscopic data to the previously acquired volumetric data may be then performed via the tracking system. Such real-time data, may be used, for example, for guidance, navigation planning, improved navigation accuracy, navigation confirmation, and treatment confirmation.
In some embodiments, the methods disclosed may further include a step for generating a 3D rendering of the target area based on a pre-operative CT scan. A display of the target area may then include a display of the 3D rendering. In another step, the tracking system may be registered with the 3D rendering. As described above, a correction of the location of the medical device with respect to the target, based on the determined offset, may then include the local updating of the registration between the tracking system and the 3D rendering in the target area. In some embodiments, the methods disclosed may further include a step for registering the fluoroscopic 3D reconstruction to the tracking system. In another step, and based on the above, a local registration between the fluoroscopic 3D reconstruction and the 3D rendering may be performed in the target area.
From the foregoing and with reference to the various figure drawings, those skilled in the art will appreciate that certain modifications can also be made to the disclosure without departing from the scope of the same. For example, although the systems and methods are described as usable with an EMN system for navigation through a luminal network such as the lungs, the systems and methods described herein may be utilized with systems that utilize other navigation and treatment devices such as percutaneous devices. Additionally, although the above-described system and method is described as used within a patient's luminal network, it is appreciated that the above-described systems and methods may be utilized in other target regions such as the liver. Further, the above-described systems and methods are also usable for transthoracic needle aspiration procedures.
Detailed embodiments of the disclosure are disclosed herein. However, the disclosed embodiments are merely examples of the disclosure, which may be embodied in various forms and aspects. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the disclosure in virtually any appropriately detailed structure.
As can be appreciated a medical instrument such as a biopsy tool or an energy device, such as a microwave ablation catheter, that is positionable through one or more branched luminal networks of a patient to treat tissue may prove useful in the surgical arena and the disclosure is directed to systems and methods that are usable with such instruments and tools. Access to luminal networks may be percutaneous or through natural orifice using navigation techniques. Additionally, navigation through a luminal network may be accomplished using image-guidance. These image-guidance systems may be separate or integrated with the energy device or a separate access tool and may include MRI, CT, fluoroscopy, ultrasound, electrical impedance tomography, optical, and/or device tracking systems. Methodologies for locating the access tool include EM, IR, echolocation, optical, and others. Tracking systems may be integrated to an imaging device, where tracking is done in virtual space or fused with preoperative or live images. In some cases the treatment target may be directly accessed from within the lumen, such as for the treatment of the endobronchial wall for COPD, Asthma, lung cancer, etc. In other cases, the energy device and/or an additional access tool may be required to pierce the lumen and extend into other tissues to reach the target, such as for the treatment of disease within the parenchyma. Final localization and confirmation of energy device or tool placement may be performed with imaging and/or navigational guidance using a standard fluoroscopic imaging device incorporated with methods and systems described above.
While several embodiments of the disclosure have been shown in the drawings, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
This application is a continuation of U.S. application Ser. No. 16/270,414, filed Feb. 7, 2019, now U.S. Pat. No. 11,364,004, which claims the benefit of the filing date of provisional U.S. Patent Application No. 62/628,017, filed Feb. 8, 2018, and provisional U.S. Patent Application No. 62/641,777, filed Mar. 12, 2018, the entire contents of each of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
5023895 | Mccroskey et al. | Jun 1991 | A |
5057494 | Sheffield | Oct 1991 | A |
5321113 | Cooper et al. | Jun 1994 | A |
5488952 | Schoolman | Feb 1996 | A |
5493595 | Schoolman | Feb 1996 | A |
5668846 | Fox et al. | Sep 1997 | A |
6003517 | Sheffield et al. | Dec 1999 | A |
6101234 | Ali et al. | Aug 2000 | A |
6201849 | Lai | Mar 2001 | B1 |
6206566 | Schuetz | Mar 2001 | B1 |
6289235 | Webber et al. | Sep 2001 | B1 |
6317621 | Graumann et al. | Nov 2001 | B1 |
6359960 | Wahl et al. | Mar 2002 | B1 |
6370224 | Simon et al. | Apr 2002 | B1 |
6379041 | Schuetz et al. | Apr 2002 | B1 |
6382835 | Graumann et al. | May 2002 | B2 |
6404843 | Vaillant | Jun 2002 | B1 |
6442288 | Haerer et al. | Aug 2002 | B1 |
6463116 | Oikawa | Oct 2002 | B1 |
6466638 | Silver et al. | Oct 2002 | B1 |
6470207 | Simon et al. | Oct 2002 | B1 |
6484049 | Seeley et al. | Nov 2002 | B1 |
6490475 | Seeley et al. | Dec 2002 | B1 |
6504892 | Ning | Jan 2003 | B1 |
6519355 | Nelson | Feb 2003 | B2 |
6522712 | Yavuz et al. | Feb 2003 | B1 |
6587539 | Oikawa | Jul 2003 | B2 |
6636623 | Nelson et al. | Oct 2003 | B2 |
6643351 | Morita et al. | Nov 2003 | B2 |
6666579 | Jensen | Dec 2003 | B2 |
6697664 | Kienzle et al. | Feb 2004 | B2 |
6707878 | Claus et al. | Mar 2004 | B2 |
6735914 | Konopka | May 2004 | B2 |
6751284 | Claus et al. | Jun 2004 | B1 |
6782287 | Grzeszczuk et al. | Aug 2004 | B2 |
6810278 | Webber et al. | Oct 2004 | B2 |
6823207 | Jensen et al. | Nov 2004 | B1 |
6834096 | Launay et al. | Dec 2004 | B2 |
6837892 | Shoham | Jan 2005 | B2 |
6851855 | Mitschke et al. | Feb 2005 | B2 |
6856826 | Seeley et al. | Feb 2005 | B2 |
6856827 | Seeley et al. | Feb 2005 | B2 |
6904121 | Claus et al. | Jun 2005 | B2 |
6909794 | Caspi | Jun 2005 | B2 |
6912265 | Hebecker et al. | Jun 2005 | B2 |
6980624 | Li et al. | Dec 2005 | B2 |
6987829 | Claus | Jan 2006 | B2 |
7048440 | Graumann et al. | May 2006 | B2 |
7082181 | Nishide et al. | Jul 2006 | B2 |
7085345 | Nukui | Aug 2006 | B2 |
7103136 | Claus et al. | Sep 2006 | B2 |
7120283 | Thieret et al. | Oct 2006 | B2 |
7123682 | Kotian et al. | Oct 2006 | B2 |
7142633 | Eberhard et al. | Nov 2006 | B2 |
7187792 | Fu et al. | Mar 2007 | B2 |
7197107 | Arai et al. | Mar 2007 | B2 |
7251522 | Essenreiter et al. | Jul 2007 | B2 |
7310436 | Li et al. | Dec 2007 | B2 |
7327865 | Fu et al. | Feb 2008 | B2 |
7327872 | Vaillant et al. | Feb 2008 | B2 |
7369695 | Zettel et al. | May 2008 | B2 |
7371067 | Anderson et al. | May 2008 | B2 |
7376213 | Wei et al. | May 2008 | B1 |
7398116 | Edwards | Jul 2008 | B2 |
7447295 | Hoheisel et al. | Nov 2008 | B2 |
7457451 | Hsieh et al. | Nov 2008 | B2 |
7499743 | Vass et al. | Mar 2009 | B2 |
7519414 | Mitschke et al. | Apr 2009 | B2 |
7519415 | Mitschke et al. | Apr 2009 | B2 |
7522755 | Avinash et al. | Apr 2009 | B2 |
7558366 | Barth et al. | Jul 2009 | B2 |
7568837 | Heigl et al. | Aug 2009 | B2 |
7603155 | Jensen et al. | Oct 2009 | B2 |
7620444 | Le et al. | Nov 2009 | B2 |
7633501 | Wood et al. | Dec 2009 | B2 |
7683338 | Ueno et al. | Mar 2010 | B2 |
7693254 | Muller et al. | Apr 2010 | B2 |
7693318 | Stalling et al. | Apr 2010 | B1 |
7711409 | Keppel et al. | May 2010 | B2 |
7712961 | Horndler et al. | May 2010 | B2 |
7742557 | Brunner et al. | Jun 2010 | B2 |
7744279 | Heath et al. | Jun 2010 | B2 |
7756244 | Mostafavi | Jul 2010 | B2 |
7761136 | Ohishi et al. | Jul 2010 | B2 |
7778690 | Boese et al. | Aug 2010 | B2 |
7801587 | Webber et al. | Sep 2010 | B2 |
7813469 | Siltanen et al. | Oct 2010 | B2 |
7826884 | Baumgart | Nov 2010 | B2 |
7831013 | Star-Lack et al. | Nov 2010 | B2 |
7835491 | Fischer et al. | Nov 2010 | B2 |
7840093 | Fu et al. | Nov 2010 | B2 |
7844094 | Jeung et al. | Nov 2010 | B2 |
7853061 | Gorges et al. | Dec 2010 | B2 |
7873236 | Li et al. | Jan 2011 | B2 |
7877132 | Rongen et al. | Jan 2011 | B2 |
7899226 | Pescatore et al. | Mar 2011 | B2 |
7912180 | Zou et al. | Mar 2011 | B2 |
7920909 | Lyon et al. | Apr 2011 | B2 |
7940885 | Stanton et al. | May 2011 | B2 |
7974450 | Ritter et al. | Jul 2011 | B2 |
7978886 | Claus et al. | Jul 2011 | B2 |
7986762 | Kunze | Jul 2011 | B2 |
7995819 | Vaillant et al. | Aug 2011 | B2 |
8045780 | Boese et al. | Oct 2011 | B2 |
8050739 | Eck et al. | Nov 2011 | B2 |
8107592 | Berman et al. | Jan 2012 | B2 |
8126224 | Zuhars et al. | Feb 2012 | B2 |
8150131 | Harer et al. | Apr 2012 | B2 |
8180132 | Gorges et al. | May 2012 | B2 |
8213564 | Dennerlein et al. | Jul 2012 | B2 |
8229061 | Hanke et al. | Jul 2012 | B2 |
8233962 | Kukuk et al. | Jul 2012 | B2 |
8275445 | Berting | Sep 2012 | B2 |
8326403 | Pescatore et al. | Dec 2012 | B2 |
8335359 | Fidrich et al. | Dec 2012 | B2 |
8411923 | Ludwig et al. | Apr 2013 | B2 |
8447009 | Flohr et al. | May 2013 | B2 |
8483358 | Allison | Jul 2013 | B2 |
8526688 | Groszmann et al. | Sep 2013 | B2 |
8542900 | Tolkowsky et al. | Sep 2013 | B2 |
8554307 | Razzaque et al. | Oct 2013 | B2 |
8565502 | Zeng et al. | Oct 2013 | B2 |
8600138 | Gorges et al. | Dec 2013 | B2 |
8625869 | Harder et al. | Jan 2014 | B2 |
8644595 | Stanton et al. | Feb 2014 | B2 |
8675996 | Liao et al. | Mar 2014 | B2 |
8693756 | Tolkowsky et al. | Apr 2014 | B2 |
8694075 | Groszmann et al. | Apr 2014 | B2 |
8699670 | Graumann et al. | Apr 2014 | B2 |
8706184 | Mohr et al. | Apr 2014 | B2 |
8750582 | Boese et al. | Jun 2014 | B2 |
8774355 | Claus et al. | Jul 2014 | B2 |
8798348 | Muller et al. | Aug 2014 | B2 |
8798353 | Claus | Aug 2014 | B2 |
8824765 | Dennerlein | Sep 2014 | B2 |
8827934 | Chopra et al. | Sep 2014 | B2 |
8831169 | Zaiki et al. | Sep 2014 | B2 |
8923476 | Paidi et al. | Dec 2014 | B2 |
8989342 | Liesenfelt et al. | Mar 2015 | B2 |
9001963 | Sowards-Emmerd et al. | Apr 2015 | B2 |
9026217 | Kokones et al. | May 2015 | B2 |
9042624 | Dennerlein | May 2015 | B2 |
9044190 | Rubner et al. | Jun 2015 | B2 |
9095306 | Gkanatsios et al. | Aug 2015 | B2 |
9104902 | Xu et al. | Aug 2015 | B2 |
9349198 | Claus et al. | May 2016 | B2 |
9375268 | Long | Jun 2016 | B2 |
9380985 | Akahori | Jul 2016 | B2 |
9401047 | Bogoni et al. | Jul 2016 | B2 |
9454813 | Westerhoff et al. | Sep 2016 | B2 |
9460512 | Ohishi et al. | Oct 2016 | B2 |
9466135 | Koehler et al. | Oct 2016 | B2 |
9743896 | Averbuch | Aug 2017 | B2 |
9918659 | Chopra et al. | Mar 2018 | B2 |
10004558 | Long et al. | Jun 2018 | B2 |
10194897 | Cedro et al. | Feb 2019 | B2 |
10373719 | Soper et al. | Aug 2019 | B2 |
10376178 | Chopra | Aug 2019 | B2 |
10405753 | Sorger | Sep 2019 | B2 |
10478162 | Barbagli et al. | Nov 2019 | B2 |
10480926 | Froggatt et al. | Nov 2019 | B2 |
10524866 | Srinivasan et al. | Jan 2020 | B2 |
10555788 | Panescu et al. | Feb 2020 | B2 |
10569071 | Harris et al. | Feb 2020 | B2 |
10603106 | Weide et al. | Mar 2020 | B2 |
10610306 | Chopra | Apr 2020 | B2 |
10638953 | Duindam et al. | May 2020 | B2 |
10639114 | Schuh et al. | May 2020 | B2 |
10674970 | Averbuch et al. | Jun 2020 | B2 |
10682070 | Duindam | Jun 2020 | B2 |
10702137 | Deyanov | Jul 2020 | B2 |
10706543 | Donhowe et al. | Jul 2020 | B2 |
10709506 | Coste-Maniere et al. | Jul 2020 | B2 |
10772485 | Schlesinger et al. | Sep 2020 | B2 |
10796432 | Mintz et al. | Oct 2020 | B2 |
10823627 | Sanborn et al. | Nov 2020 | B2 |
10827913 | Ummalaneni et al. | Nov 2020 | B2 |
10835153 | Rafii-Tari et al. | Nov 2020 | B2 |
10885630 | Li et al. | Jan 2021 | B2 |
20010024796 | Selifonov et al. | Sep 2001 | A1 |
20020147462 | Mair et al. | Oct 2002 | A1 |
20030013972 | Makin | Jan 2003 | A1 |
20030031291 | Yamamoto et al. | Feb 2003 | A1 |
20030128801 | Eisenberg et al. | Jul 2003 | A1 |
20030130576 | Seeley et al. | Jul 2003 | A1 |
20030181809 | Hall et al. | Sep 2003 | A1 |
20030190065 | Hamill et al. | Oct 2003 | A1 |
20040030585 | Sariel | Feb 2004 | A1 |
20040120981 | Nathan | Jun 2004 | A1 |
20050059879 | Sutherland et al. | Mar 2005 | A1 |
20050178970 | Amemiya et al. | Aug 2005 | A1 |
20060142984 | Weese et al. | Jun 2006 | A1 |
20070030947 | Popescu | Feb 2007 | A1 |
20080045938 | Weide et al. | Feb 2008 | A1 |
20100284601 | Rubner et al. | Nov 2010 | A1 |
20110152676 | Groszmann et al. | Jun 2011 | A1 |
20120046521 | Hunter et al. | Feb 2012 | A1 |
20120289825 | Rai | Nov 2012 | A1 |
20130172732 | Kiraly et al. | Jul 2013 | A1 |
20130223702 | Holsing et al. | Aug 2013 | A1 |
20130303945 | Blumenkranz et al. | Nov 2013 | A1 |
20140035798 | Kawada et al. | Feb 2014 | A1 |
20150148690 | Chopra et al. | May 2015 | A1 |
20150265368 | Chopra et al. | Sep 2015 | A1 |
20160005168 | Merlet et al. | Jan 2016 | A1 |
20160120521 | Weingarten | May 2016 | A1 |
20160157939 | Larkin et al. | Jun 2016 | A1 |
20160183841 | Duindam et al. | Jun 2016 | A1 |
20160192860 | Allenby et al. | Jul 2016 | A1 |
20160287344 | Donhowe et al. | Oct 2016 | A1 |
20160302747 | Averbuch | Oct 2016 | A1 |
20170032512 | Sun | Feb 2017 | A1 |
20170112571 | Thiel et al. | Apr 2017 | A1 |
20170112576 | Coste-Maniere et al. | Apr 2017 | A1 |
20170209071 | Zhao et al. | Jul 2017 | A1 |
20170265952 | Donhowe et al. | Sep 2017 | A1 |
20170311844 | Zhao et al. | Nov 2017 | A1 |
20170319165 | Averbuch | Nov 2017 | A1 |
20180078318 | Barbagli et al. | Mar 2018 | A1 |
20180144092 | Flitsch et al. | May 2018 | A1 |
20180153621 | Duindam et al. | Jun 2018 | A1 |
20180235709 | Donhowe et al. | Aug 2018 | A1 |
20180240237 | Donhowe et al. | Aug 2018 | A1 |
20180256262 | Duindam et al. | Sep 2018 | A1 |
20180263706 | Averbuch | Sep 2018 | A1 |
20180279852 | Rafii-Tari et al. | Oct 2018 | A1 |
20180325419 | Zhao et al. | Nov 2018 | A1 |
20190000559 | Berman et al. | Jan 2019 | A1 |
20190000560 | Berman et al. | Jan 2019 | A1 |
20190008413 | Duindam et al. | Jan 2019 | A1 |
20190038365 | Soper et al. | Feb 2019 | A1 |
20190065209 | Mishra et al. | Feb 2019 | A1 |
20190110839 | Rafii-Tari et al. | Apr 2019 | A1 |
20190175062 | Rafii-Tari et al. | Jun 2019 | A1 |
20190175799 | Hsu et al. | Jun 2019 | A1 |
20190183318 | Froggatt et al. | Jun 2019 | A1 |
20190183585 | Rafii-Tari et al. | Jun 2019 | A1 |
20190183587 | Rafii-Tari et al. | Jun 2019 | A1 |
20190192234 | Gadda et al. | Jun 2019 | A1 |
20190209016 | Herzlinger et al. | Jul 2019 | A1 |
20190209043 | Zhao et al. | Jul 2019 | A1 |
20190216548 | Ummalaneni | Jul 2019 | A1 |
20190239723 | Duindam et al. | Aug 2019 | A1 |
20190239831 | Chopra | Aug 2019 | A1 |
20190250050 | Sanborn et al. | Aug 2019 | A1 |
20190254649 | Walters et al. | Aug 2019 | A1 |
20190269470 | Barbagli et al. | Sep 2019 | A1 |
20190269818 | Dhanaraj et al. | Sep 2019 | A1 |
20190269819 | Dhanaraj et al. | Sep 2019 | A1 |
20190272634 | Li et al. | Sep 2019 | A1 |
20190298160 | Ummalaneni et al. | Oct 2019 | A1 |
20190298451 | Wong et al. | Oct 2019 | A1 |
20190320878 | Duindam et al. | Oct 2019 | A1 |
20190320937 | Duindam et al. | Oct 2019 | A1 |
20190336238 | Yu et al. | Nov 2019 | A1 |
20190343424 | Blumenkranz et al. | Nov 2019 | A1 |
20190350659 | Wang et al. | Nov 2019 | A1 |
20190365199 | Zhao et al. | Dec 2019 | A1 |
20190365479 | Rafii-Tari | Dec 2019 | A1 |
20190365486 | Srinivasan et al. | Dec 2019 | A1 |
20190380787 | Ye et al. | Dec 2019 | A1 |
20200000319 | Saadat et al. | Jan 2020 | A1 |
20200000526 | Zhao | Jan 2020 | A1 |
20200008655 | Schlesinger et al. | Jan 2020 | A1 |
20200030044 | Wang et al. | Jan 2020 | A1 |
20200030461 | Sorger | Jan 2020 | A1 |
20200038750 | Kojima | Feb 2020 | A1 |
20200043207 | Lo et al. | Feb 2020 | A1 |
20200046431 | Soper et al. | Feb 2020 | A1 |
20200046436 | Tzeisler et al. | Feb 2020 | A1 |
20200054399 | Duindam et al. | Feb 2020 | A1 |
20200054408 | Schuh et al. | Feb 2020 | A1 |
20200060771 | Lo et al. | Feb 2020 | A1 |
20200069192 | Sanborn et al. | Mar 2020 | A1 |
20200077870 | Dicarlo et al. | Mar 2020 | A1 |
20200078023 | Cedro et al. | Mar 2020 | A1 |
20200078095 | Chopra et al. | Mar 2020 | A1 |
20200078103 | Duindam et al. | Mar 2020 | A1 |
20200085514 | Blumenkranz | Mar 2020 | A1 |
20200109124 | Pomper et al. | Apr 2020 | A1 |
20200129045 | Prisco | Apr 2020 | A1 |
20200129239 | Bianchi et al. | Apr 2020 | A1 |
20200138514 | Blumenkranz et al. | May 2020 | A1 |
20200138515 | Wong | May 2020 | A1 |
20200142013 | Wong | May 2020 | A1 |
20200155116 | Donhowe et al. | May 2020 | A1 |
20200155232 | Wong | May 2020 | A1 |
20200170623 | Averbuch | Jun 2020 | A1 |
20200170720 | Ummalaneni | Jun 2020 | A1 |
20200179058 | Barbagli et al. | Jun 2020 | A1 |
20200188021 | Wong et al. | Jun 2020 | A1 |
20200188038 | Donhowe et al. | Jun 2020 | A1 |
20200205903 | Srinivasan et al. | Jul 2020 | A1 |
20200205904 | Chopra | Jul 2020 | A1 |
20200214664 | Zhao et al. | Jul 2020 | A1 |
20200229679 | Zhao et al. | Jul 2020 | A1 |
20200242767 | Zhao et al. | Jul 2020 | A1 |
20200275860 | Duindam | Sep 2020 | A1 |
20200297442 | Adebar et al. | Sep 2020 | A1 |
20200315554 | Averbuch et al. | Oct 2020 | A1 |
20200330795 | Sawant et al. | Oct 2020 | A1 |
20200352427 | Deyanov | Nov 2020 | A1 |
20200364865 | Donhowe et al. | Nov 2020 | A1 |
20200383750 | Kemp et al. | Dec 2020 | A1 |
20210000524 | Barry et al. | Jan 2021 | A1 |
Number | Date | Country |
---|---|---|
0013237 | Jul 2003 | BR |
0116004 | Jun 2004 | BR |
0307259 | Dec 2004 | BR |
2004PI12298 | Sep 2006 | BR |
0412298 | Sep 2006 | BR |
112018003862 | Oct 2018 | BR |
105232152 | Jan 2016 | CN |
1644519 | Dec 2008 | CZ |
486540 | Sep 2016 | CZ |
2709512 | Aug 2017 | CZ |
2884879 | Jan 2020 | CZ |
0486540 | May 1992 | EP |
0846275 | Jun 1998 | EP |
1326531 | Jul 2003 | EP |
1644519 | Dec 2008 | EP |
2141497 | Jan 2010 | EP |
2709512 | Mar 2014 | EP |
2884879 | Jun 2015 | EP |
3413830 | Sep 2019 | EP |
3478161 | Feb 2020 | EP |
3641686 | Apr 2020 | EP |
3644885 | May 2020 | EP |
3644886 | May 2020 | EP |
3749239 | Dec 2020 | EP |
H11253433 | Sep 1999 | JP |
2010520770 | Jun 2010 | JP |
2012020023 | Feb 2012 | JP |
PA03005028 | Jan 2004 | MX |
PA03000137 | Sep 2004 | MX |
PA03006874 | Sep 2004 | MX |
225663 | Jan 2005 | MX |
226292 | Feb 2005 | MX |
PA03010507 | Jul 2005 | MX |
PA05011725 | May 2006 | MX |
06011286 | Mar 2007 | MX |
PA06011286 | Mar 2007 | MX |
246862 | Jun 2007 | MX |
2007006441 | Aug 2007 | MX |
265247 | Mar 2009 | MX |
284569 | Mar 2011 | MX |
9006636 | Jun 1990 | WO |
2017139591 | Aug 2017 | WO |
Entry |
---|
Extended European Search Report issued in European Patent Application No. 19751690.9 dated Oct. 29, 2021. |
International Search Report and Written Opinion of the International Searching Authority issued in corresponding Appl. No. PCT/US2019/017231 dated May 30, 2019 (12 pages). |
Notice of First Office Action issued in Chinese Patent application No. 201980012379.9 dated Apr. 28, 2023 with English translation (through Google translate). |
Notice of Allowance issued in Japanese Patent Application No. 2020-542153 dated Jul. 18, 2023 with English translation. |
Number | Date | Country | |
---|---|---|---|
20220313190 A1 | Oct 2022 | US |
Number | Date | Country | |
---|---|---|---|
62641777 | Mar 2018 | US | |
62628017 | Feb 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16270414 | Feb 2019 | US |
Child | 17845936 | US |